stockrow
Saturday 7 November 2026
Export PETS’s income statement to Excel — free account
PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025.
- Revenue
- −19.9%
- EPS
- +83.0%
- Free cash flow
- +38.6%
Quarter to June 2026, against a year earlier
1.22
0.02
−1.61%
Follow PETS
Alert me
PetMed Express, Inc. (PETS) P/E ratio
PetMed Express, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 550× (February 2025) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 65.4× | 133.66% |
| FY2022 | 28.0× | (4.91%) |
| FY2021 | 29.4× | 30.87% |
| FY2020 | 22.5× | 79.91% |
| FY2019 | 12.5× | (44.21%) |
| FY2018 | 22.4× | 31.25% |
| FY2017 | 17.1× | (2.80%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 550×
Ten-year median
18.9×
Current reading's percentile
24
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SCNX Scienture Holdings, Inc. compare | n/m |
| RDGT Ridgetech Inc. compare | n/m |
| PETS PetMed Express, Inc. | n/m |
| HITI High Tide Inc. compare | n/m |
| POM Pomdoctor Limited - Sponsored ADR compare | — |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)